1. Home
  2. Conferences
  3. Biocides Symposium 2024
  4. programme

Agenda

  1. SESSION 4: Best practices for managing the BPR

  2. Tips and tricks for applicant on how to create a solid dossier

  3. Take aways from a competent authority (CA) seminar on best practice for national authorisations

  4. How to avoid pitfalls with mutual recognition and same biocidal products application

    Karolina Pastuszko Karolina Pastuszko
    Chief Specialist, The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products

  5. Best practice for how to create a label, also avoiding the use of misleading terms

    Leticia Ungaretti Haberbeck Leticia Ungaretti Haberbeck
    Senior Regulatory Specialist II, Ecolab

  6. Q&A

  7. Refreshment break

  8. Best practice on where to find relevant guidance

    Jules Bossert, Sector Group Manager B4E, Cefic??

  9. How to avoid pitfalls with union authorisations

  10. How to avoid pitfalls for biocidal product families (BPF): Lessons learned so far with quat families

  11. Q&A

  12. Lunch and Networking

  13. SESSION 5: The latest testing an modelling updates

  14. How to assess biocides and residues in water treatment processes

    Ursula Karges, Water Resource Management, IWW Water Centre??

  15. Substances of concern in BPF: Case studies

    Daniela Romano Daniela Romano
    Senior Consultant for Biocidal Products, knoell Germany GmbH

  16. 'To bee or not to bee, that is the question!' New guidance on risk assessment for bees - impact on PT18 biocides

    Naomi Young
    Managing Consultant, Ramboll

  17. Q&A

  18. Refreshment break

  19. SESSION 6: Important efficacy considerations

  20. Efficacy data, from primitive to primordial

    • How efficacy data influences many other aspects of a BPR product dossier??
    • How to stay abreast of critical developments related to efficacy testing??
    • How to increase acceptance of efficacy test results????
    Stijn Van Hees Stijn Van Hees
    Senior Project Scientist, ARCHE Consulting

  21. Residual activity versus treated articles

  22. Q&A

  23. Close of conference

View previous day

/ next day
Back to top